Jim Cramer Says This Retailer Yields 3%: 'Which Is Quite Good'

by Avi Kapoor Benzinga Staff Writer

Zinger Key Points

Jim Cramer likes animal health company Zoetis, which raised its 2024 guidance above estimates.
"I’ve liked Con Ed for, I don’t know, maybe 70 points," Cramer said when asked about Consolidated Edison.
Get New Picks of the Market's Top Stocks

On CNBC's “Mad Money Lightning Round,” Jim Cramer said Target Corporation TGT reported a “very, very good” quarter.

“It does yield 3%, which is actually quite good,” he added.

On Aug. 21, Target posted stellar second-quarter results outperformed earnings and sales expectations and prompted an optimistic boost to its full-year profit outlook.

Quarterly adjusted earnings per share totaled $2.57 (+40%), beating the street view of $2.20. Target reported sales of $25.45 billion (+2.7%), exceeding the analyst consensus of $25.229 billion.

Cramer also likes Zoetis Inc. ZTS.

On Aug. 6, Zoetis reported better-than-expected second-quarter financial results and raised its 2024 guidance above estimates. The animal health company reported second-quarter revenue of $2.36 billion, up 8% year-over-year on reported and 11% on an operational basis, beating the consensus of $2.31 billion.

When asked about PROCEPT BioRobotics Corporation PRCT, he said, “It's been a rocket, but I think if you're going to be in robotics, you have to be in ISRG.”

On Sept. 3, Truist Securities analyst Richard Newitter maintained PROCEPT BioRobotics with a Buy and raised the price target from $74 to $95.

“I've liked Con Ed for, I don't know, maybe 70 points,” Cramer said when asked about Consolidated Edison, Inc. ED. “As long as it's around, above three, I think the stock can still project itself even higher.”

On Aug. 1, Consolidated Edison reported quarterly earnings of 59 cents per share which beat the analyst consensus estimate of 57 cents per share. The company reported quarterly sales of $3.22 billion which beat the analyst consensus estimate of $3.18 billion.

Price Action: